In addition, some studies associated SEC61G overexpression with worse survival in hepatocellular carcinoma, head and neck squamous carcinoma, glioblastoma and lung adenocarcinoma [91,92,93,94]. This evidence concerns the gene SEC61G and hepatocellular carcinoma.